Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
08/2002
08/29/2002WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2002066442A1 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
08/29/2002WO2002066441A1 Diaminopyrazole compounds and the use thereof in the oxidation dyeing of keratinous fibres
08/29/2002WO2002066440A1 Diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres
08/29/2002WO2002066439A1 Pyrazole derivative, intermediate therefor, processes for producing these, and herbicide containing these as active ingredient
08/29/2002WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/29/2002WO2002066425A2 Compositions and methods for hydration of terminal alkynes
08/29/2002WO2002066423A1 Process for preparation of polyfluoroalkylsulfenyl compounds
08/29/2002WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof
08/29/2002US20020120149 Substituted hydrazine derivatives
08/29/2002US20020119972 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
08/29/2002CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002CA2435446A1 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
08/29/2002CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/28/2002EP1233944A2 Coupling condensation synthesis of heterocycles
08/28/2002EP1140926B1 Azadioxacycloalkenes and their use for combating harmful fungi and animal pests
08/28/2002EP0846110B1 Thf-containing sulfonamide inhibitors of aspartyl protease
08/28/2002CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same
08/27/2002US6441043 Glyoxylic acid amides
08/27/2002US6441023 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection
08/27/2002US6441018 Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
08/27/2002US6440963 Use of selective COX-2 inhibitors for the treatment of urinary incontinence
08/27/2002US6440941 Derivatives of erythromycin, their preparation process and their use as medicaments
08/22/2002WO2002064565A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
08/22/2002WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
08/22/2002WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals
08/22/2002WO2002064136A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/22/2002US20020115868 Novel process for making 5-substituted pyrazoles
08/22/2002US20020115860 Compositions and methods for hydration of terminal alkynes
08/22/2002US20020115670 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
08/21/2002EP1232150A1 Urea derivatives as anti-inflammatory agents
08/21/2002EP1231939A2 Oncolytic combinations for the treatment of cancer
08/21/2002EP1231919A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
08/21/2002EP0675715B1 Cell differentiation induction with mevalonate and mevalonolactone derivatives
08/20/2002US6437149 Cationic aminoanthraquinones, their use for dyeing keratinous fibers, dyeing compositions containing them and methods of dyeing
08/20/2002US6436999 Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them
08/20/2002US6436985 Disubstituted pyrazolines and triazolines as factor Xa inhibitors
08/20/2002US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
08/20/2002US6436915 Antiproliferative and antitumor agents and angiogenesis inhibitors
08/15/2002WO2002062750A1 Cannabinoid receptor ligands
08/15/2002WO2001096307A3 Cycloalkyl alkanoic acids as integrin receptor antagonists
08/15/2002US20020111498 One-pot process, reacting an ether derivative with an acylating agent of an acylhalide, ester, or anhydride derivative in the presence of a base and activating agent followed by the addition in situ of a hydrazine
08/15/2002US20020111497 Reacting azolide salts with phosgene in an aromatic compound or an ether as solvent
08/15/2002US20020111374 Estrogen receptor modulators
08/15/2002US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders
08/15/2002US20020111352 Parasiticides
08/14/2002EP1230245A2 Novel herbicides
08/14/2002EP1230244A2 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
08/14/2002EP1230222A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists
08/14/2002EP1230221A1 Method for producing n-substituted 2-pyrazoline-5-one
08/14/2002EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/14/2002EP0754683B1 Ether compound, use thereof, and intermediate for producing the compound
08/14/2002DE10103565A1 Zusammensetzungen, enthaltend einen Ruthenium(III)-komplex und einen Heterocyclus Compositions comprising a ruthenium (III) complex and a heterocycle
08/13/2002US6433210 Process for producing substituted arylpyrazoles
08/13/2002US6433002 Pesticidal 1-polyarylpyrroles
08/13/2002US6432999 Pyrazole substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
08/13/2002US6432995 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor from cells
08/13/2002US6432984 Cannabinoid receptor antagonists; treatment of obesity, drug addiction, alcholism, psychological, and eating disorders
08/13/2002US6432881 Applying to plant, seeds, environment; 2-benzoylcyclohexane-1,3-dione compound
08/13/2002CA2060573C N-(aryloxyalkyl)heteroaryl-8-azabicyclo¬3.2.1|octanes, intermediates and a process for the preparation thereof and their use as medicaments
08/08/2002WO2002024690A8 Efficient process for the preparation of a factor xa inhibitor
08/08/2002WO2001056555A3 Use of cox-2 inhibitors for the treatment of constipation
08/08/2002US20020107277 Novel method and use
08/08/2002US20020107276 Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist
08/08/2002CA2672805A1 Pyrimidine derivatives
08/07/2002EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity
08/07/2002CN1362953A Pyrazole compositions useful as inhibitors of ERK
08/07/2002CN1362397A Dialkoyl-halogen phenyl substituted keto-enol
08/06/2002CA2223237C 1-phenyl-pyrazole derivatives and their use as parasiticidal agents
08/01/2002WO2002059135A1 Compositions containing a ruthenium(iii) complex and a heterocycle
08/01/2002WO2002059126A1 Process for the preparation of a pyrazolo[4,3-d]pyrimidine derivative
08/01/2002WO2002059110A1 Pyrimidineamines as angiogenesis modulators
08/01/2002WO2002059097A1 Novel gd(iii) ligands with bi- and bis-azolic structures
08/01/2002WO2002059088A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
08/01/2002WO2002059086A1 Carboxamides as fungicides in agriculture
08/01/2002WO2002059082A2 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
08/01/2002WO2002059080A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
08/01/2002WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
08/01/2002US20020103381 Useful in pharmaceutical industry, such as antiinflammatory or antiarthritic agents; solid phase synthesis; esterification of a hydroxylated solid support, treating wtih trimethylsilyldiazomethane, deprotecting
08/01/2002US20020103245 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents
08/01/2002US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same
08/01/2002US20020103229 Indazole derivatives as JNK inhibitors and compositions and methods related thereto
08/01/2002US20020103203 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
08/01/2002US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone
08/01/2002US20020103185 Pyrazole derivatives
08/01/2002US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization
08/01/2002DE10103647A1 Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates A process for preparing a pyrazolo (4,3-d) pyrimidine derivative
08/01/2002CA2435884A1 Process for the preparation of a pyrazolo[4,3-d]pyrimidine derivative
08/01/2002CA2435829A1 Trisubstituted carbocyclic cyclophilin binding compounds and their use
08/01/2002CA2435566A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
08/01/2002CA2433819A1 Carboxamides as fungicides in agriculture
08/01/2002CA2432122A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
07/2002
07/31/2002EP1226127A2 Uracil substituted phenyl sulfamoyl carboxamides
07/31/2002EP1226123A1 Cyano compounds as factor xa inhibitors
07/31/2002EP1225894A1 Fab i inhibitors
07/31/2002EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
07/31/2002EP1225882A1 Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
07/31/2002CN1361770A Heteroaromatic ring compounds
07/30/2002US6426366 Pharmaceutical compositions comprising tyrphostins
07/30/2002US6426348 For therapy of inflammation associated with chronic inflammatory diseases such as rheumatoid arthritis (ra), multiple sclerosis, (ms), asthma, and inflammatory bowel disease (i bd)